News
23 June 2015

NCI Funding Opportunity Announcement: Smoking Cessation within the Context of Lung Cancer Screening

Research Project Grant

The goal of this Funding Opportunity Announcement is to improve the effectiveness and/or implementation of smoking cessation interventions delivered to current smokers who undergo low-dose computed tomography (LDCT) lung cancer screening. The proposed projects must be aimed at determining:

a) the key components and characteristics of an effective smoking cessation intervention delivered in the LDCT setting; and/or

b) characteristics of an implementation strategy to optimally incorporate existing evidence-based smoking cessation intervention(s) into the LDCT setting.

The projects must include prospective, comparative evaluation of the intervention(s) in terms of the rates of cessation and sustained abstinence (6-12 months after cessation) among current smokers undergoing screening. The LDCT screening site must be the essential context for the delivery of the cessation intervention, although interventions may also include services provided outside the site before or after screening.

This project is led by the National Institutes of Health (NIH) and the National Cancer Institute (NCI).

Letter of Intent Due Date: September 8, 2015

Application Due Date: October 8, 2015, by 5:00 PM local time of applicant organisation.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

For more information, requirements, or to apply: http://grants.nih.gov/grants/guide/rfa-files/RFA-CA-15-011.html

Last update

Friday 07 June 2019

Share this page

Related content

Young Indian woman in graduation gown holding a bouquet of yellow flowers celebrating flanked by her father on her left and mother on her right

Diagnosed with stage 3B lung cancer at age 26, Rasika Bombatkar describes how assumptions about who gets lung cancer, social stigma, and limited access to psychosocial support, shaped her experience. She now volunteers with Lung Connect India Foundation, a UICC member. 

In the medical laboratory, the patient undergoes an MRI or CT scan under the supervision of a radiologist, in the control room, the doctor observes the procedure and monitors the scan results.

Reflecting on World Cancer Day, Israel Lowy, MD, PhD, Senior Vice President, Clinical Development Unit Head, Oncology at Regeneron, a UICC partner, shares his view on the future of personalised medicine in lung cancer and the importance of people-centred care.